Catechin ameliorates doxorubicin-induced neuronal cytotoxicity in in vitro and episodic memory deficit in in vivo in Wistar rats
Cognitive dysfunction by chemotherapy compromises the quality of life in cancer patients. Tea polyphenols are known chemopreventive agents. The present study was designed to evaluate the neuroprotective potential of (+) catechin hydrate (catechin), a tea polyphenol, in IMR-32 neuroblastoma cells in vitro and alleviation of episodic memory deficit in Wistar rats in vivo against a widely used chemotherapeutic agent, Doxorubicin (DOX). In vitro, neuroprotective studies were assessed in undifferentiated IMR-32 cells using percentage viability and in differentiated cells by neurite length. These studies showed catechin increased percentage viability of undifferentiated IMR-32 cells. Catechin pretreatment also showed an increase in neurite length of differentiated cells. In vivo neuroprotection of catechin was evaluated using novel object recognition task in time-induced memory deficit model at 50, 100 and 200 mg/kg dose and DOX-induced memory deficit models at 100 mg/kg dose. The latter model was developed by injection of DOX (2.5 mg/kg, i.p.) in 10 cycles over 50 days in Wistar rats. Catechin showed a significant reversal of time-induced memory deficit in a dose-dependent manner and prevention of DOX-induced memory deficit at 100 mg/kg. In addition, catechin treatment showed a significant decrease in oxidative stress, acetylcholine esterase and neuroinflammation in the hippocampus and cerebral cortex in DOX-induced toxicity model. Hence, catechin may be a potential adjuvant therapy for the amelioration of DOX-induced cognitive impairment which may improve the quality of life of cancer survivors. This improvement might be due to the elevation of antioxidant defense, prevention of neuroinflammation and inhibition of acetylcholine esterase enzyme.
KeywordsChemobrain Doxorubicin (+) Catechin hydrate IMR-32 cells Neuroprotection Episodic memory
We thank AICTE (RPS Scheme—Grant No. 20/AICTE/RIFD/RPS (POLICY-1)64/2013-14) and Manipal University for infrastructural support.
- Ahmed ME, Khan MM, Javed H, Vaibhav K, Khan A, Tabassum R, Ashafaq M, Islam F, Safhi MM, Islam F (2013) Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type. Neurochem Int 62:492–501. doi: 10.1016/j.neuint.2013.02.006 CrossRefGoogle Scholar
- Aluise CD, Sultana R, Tangpong J, Vore M, Clair DS, Moscow JA, Butterfield DA (2010a) Chemo brain clinical breast cancer (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction, Chemo Fog. Springer, Berlin, pp 147–156Google Scholar
- Aluise CD, Sultana R, Tangpong J, Vore M, St Clair D, Moscow JA, Butterfield DA (2010b) Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Adv Exp Med Biol 678:147–156CrossRefGoogle Scholar
- Christen Y (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr 71:621S–629SGoogle Scholar
- Fawcett JR, Bordayo EZ, Jackson K, Liu H, Peterson J, Svitak A, Frey Ii WH (2002) Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer’s brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants. Brain Res 950:10–20CrossRefGoogle Scholar
- Goodman LS (1996) Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New YorkGoogle Scholar
- Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175Google Scholar
- Rang HP (2007) Rang and Dale’s pharmacology. Churchill Livingstone, Philadelphia, pp 672–674Google Scholar
- Simon L, Srinivasan KK, Kumar N, Reddy ND, Biswas S, Rao CM, Moorkoth S (2016) Selected novel 5′-amino-2′-hydroxy-1,3-diaryl-2-propen-1-ones arrest cell cycle of Hct-116 in G0/G1 phase. EXCLI J 15:21–32Google Scholar
- Walle T (2007) Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Seminars in cancer biology. Elsevier, New York, pp 354–362Google Scholar